Pilot Study of Internet Drug Availability, Pricing, and Quality

Background

Internet-sourced drugs are often considered suspect. The World Health Organization reports that drugs from websites that conceal their physical address are counterfeit in over 50 percent of cases; the U.S. Food and Drug Administration (FDA) works with the National Association of Boards of Pharmacy (NABP) to regularly update a list of websites likely to sell drugs that are illegal or of questionable quality. Some pressure groups and politicians have called for banning Internet drug purchasing--even while others laud it as a convenient, cost-effective way for consumers to access drugs.

Methods and Findings

This study examines drug purchasing over the Internet, by comparing the sales of five popular drugs from a selection of websites stratified by NABP or other ratings. The drugs were assessed for price, conditions of purchase, and basic quality.

Prices and conditions of purchase varied widely. Some websites advertised single pills while others only permitted the purchase of large quantities. Not all websites delivered the exact drugs ordered, some delivered no drugs at all; many websites shipped from multiple international locations, and from locations that were different from those advertised on the websites.

All drug samples were tested against approved U.S. brand formulations using Raman spectrometry. Many (13) websites substituted drugs, often in different formulations from the brands requested. These drugs, some of which were probably generics or copy versions, could not be assessed accurately. Of those drugs which could be assessed, failures ranged from 0% (0 out of 24) at "approved" websites to 8% (1 out of 12) at websites "highly not recommended" by the NABP. One of the two drugs received from "not recommended" and "highly not recommended" websites that could not be linked directly to a website for purchase because the packaging lacked appropriate labeling failed spectrometry testing.

Conclusions

Some websites did not comply with purchaser requests for brand-name drugs, which limited the ability to assess quality. Of those which could be assessed, most drugs (except Viagra) passed spectrometry testing. Of those which failed, few could be identified either by a country of manufacture listed on the packaging, or by the physical location of the website pharmacy. If confirmed by future studies on other drug samples, then U.S. consumers may be able to reduce their risk by relying on tools like the NABP "recommended" and "not recommended" lists and by using common sense when examining packaging and pills. Future studies should assess drugs from unapproved websites in a linear fashion--orders should be staggered over several months to ensure provenance of each drug received. With few identifiable marks on packages received from these websites one cannot be sure of the source if multiple orders are made within a few weeks.

Click here to view this paper as an Adobe Acrobat PDF.

Roger Bate is a resident fellow at AEI. Kimberly Hess is a researcher and editor at Africa Fighting Malaria. Robert Brush is an application scientist at Ahura Scientific, Inc.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

Roger
Bate
  • Roger Bate is an economist who researches international health policy, with a particular focus on tropical disease and substandard and counterfeit medicines. He also writes on general development policy in Asia and Africa. He writes regularly for AEI's Health Policy Outlook.
  • Phone: 202-828-6029
    Email: rbate@aei.org
  • Assistant Info

    Name: Katherine Earle
    Phone: (202) 862-5872
    Email: katherine.earle@aei.org

What's new on AEI

image Getting it right: US national security policy and al Qaeda since 2011
image Net neutrality rundown: What the NPRM means for you
image The Schuette decision
image Snatching failure from victory in Afghanistan
AEI on Facebook
Events Calendar
  • 21
    MON
  • 22
    TUE
  • 23
    WED
  • 24
    THU
  • 25
    FRI
Wednesday, April 23, 2014 | 12:00 p.m. – 1:30 p.m.
Graduation day: How dads’ involvement impacts higher education success

Join a diverse group of panelists — including sociologists, education experts, and students — for a discussion of how public policy and culture can help families lay a firmer foundation for their children’s educational success, and of how the effects of paternal involvement vary by socioeconomic background.

Thursday, April 24, 2014 | 12:00 p.m. – 1:30 p.m.
Getting it right: A better strategy to defeat al Qaeda

This event will coincide with the release of a new report by AEI’s Mary Habeck, which analyzes why current national security policy is failing to stop the advancement of al Qaeda and its affiliates and what the US can do to develop a successful strategy to defeat this enemy.

Event Registration is Closed
Friday, April 25, 2014 | 9:15 a.m. – 1:15 p.m.
Obamacare’s rocky start and uncertain future

During this event, experts with many different views on the ACA will offer their predictions for the future.   

Event Registration is Closed
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.